Decreased mitochondrial DNA mutagenesis in human colorectal cancer.
Decreased mitochondrial DNA mutagenesis in human colorectal cancer.
复制标题
DOI:
10.1371/journal.pgen.1002689
复制
发表时间:
2012
期刊:
影响因子:
4.5
通讯作者:
Bielas JH
中科院分区:
文献类型:
--
作者:
Ericson NG;Kulawiec M;Vermulst M;Sheahan K;O'Sullivan J;Salk JJ;Bielas JH
Genome instability is regarded as a hallmark of cancer. Human tumors frequently carry clonally expanded mutations in their mitochondrial DNA (mtDNA), some of which may drive cancer progression and metastasis. The high prevalence of clonal mutations in tumor mtDNA has commonly led to the assumption that the mitochondrial genome in cancer is genetically unstable, yet this hypothesis has not been experimentally tested. In this study, we directly measured the frequency of non-clonal (random) de novo single base substitutions in the mtDNA of human colorectal cancers. Remarkably, tumor tissue exhibited a decreased prevalence of these mutations relative to adjacent non-tumor tissue. The difference in mutation burden was attributable to a reduction in C∶G to T∶A transitions, which are associated with oxidative damage. We demonstrate that the lower random mutation frequency in tumor tissue was also coupled with a shift in glucose metabolism from oxidative phosphorylation to anaerobic glycolysis, as compared to non-neoplastic colon. Together these findings raise the intriguing possibility that fidelity of mitochondrial genome is, in fact, increased in cancer as a result of a decrease in reactive oxygen species-mediated mtDNA damage. Mitochondria are the intracellular organelles responsible for energy production in eukaryotic cells. They are unique in that they contain their own DNA (mtDNA), which encodes genes important for mitochondrial function and is the cell's only genetic material stored outside the nucleus. Mutations in both nuclear and mtDNA are believed to have a role in tumor growth and metastasis. While it is well established that nuclear DNA has an increased overall burden of mutations in human cancers, this has not been investigated in mtDNA. Here we use a highly sensitive assay to determine mutational load in mtDNA isolated from patient-matched normal and cancerous colonic tissues. Surprisingly, we discovered that the frequency of mutations in mtDNA is actually decreased in tumors relative to healthy tissues, suggesting that, unlike in nuclear DNA, accelerated mutagenesis in mtDNA does not facilitate a cancer's development and may even hinder it. These findings raise the possibility that mitochondrial-targeted cancer therapeutics focused on directly increasing mtDNA damage and mutation might effectively suppress malignant growth.
登录
查看更多内容
影响因子:
2.8
作者:
Arnold, Rebecca S.;Sun, Carrie Q.;Richards, Jendai C.;Grigoriev, Galina;Coleman, Ilsa M.;Nelson, Peter S.;Hsieh, Chia-Ling;Lee, Jae K.;Xu, Zhiheng;Rogatko, Andre;Osunkoya, Adeboye O.;Zayzafoon, Majd;Chung, Leland;Petros, John A.
通讯作者:
Petros, John A.
DOI:
10.1073/pnas.0607057103
发表时间:
2006-11-28
影响因子:
11.1
作者:
Bielas, Jason H.;Loeb, Keith R.;Loeb, Lawrence A.
通讯作者:
Loeb, Lawrence A.
影响因子:
56.9
作者:
Ishikawa, Kaori;Takenaga, Keizo;Hayashi, Jun-Ichi
通讯作者:
Hayashi, Jun-Ichi
DOI:
10.1111/j.1532-5415.1972.tb00787.x
发表时间:
1972-01-01
影响因子:
6.3
作者:
HARMAN, D
通讯作者:
HARMAN, D
影响因子:
2.8
作者:
Bielas, JH;Loeb, LA
通讯作者:
Loeb, LA